Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1.Age -18- 60 years (Both sex) <br/ >2.Confirmed COVID 19 patient with positive RT-PCR <br/ >3.Mild symptomatic or asymptomatic patients having no signs of severe disease (NEWS score â?¤6) and no comorbidity at screening <br/ >4.Subject willing to provide consent and follow up for study duration <br/ >

1.Age -18- 60 years (Both sex) <br/ >2.Confirmed COVID 19 patient with positive RT-PCR <br/ >3.Mild symptomatic or asymptomatic patients having no signs of severe disease (NEWS score â?¤6) and no comorbidity at screening <br/ >4.Subject willing to provide consent and follow up for study duration <br/ >

Nov. 13, 2021, 5:33 p.m. oms

Sept. 8, 2021, 1:30 a.m. oms

1.Age -18- 60 years (Both sex) <br/ >2.Confirmed COVID 19 patient with positive RT-PCR <br/ >3.Mild symptomatic or asymptomatic patients having no signs of severe disease (NEWS score â?¤6) and no comorbidity at screening <br/ >4.Subject willing to provide consent and follow up for study duration <br/ >

1.Age -18- 60 years (Both sex) <br/ >2.Confirmed COVID 19 patient with positive RT-PCR <br/ >3.Mild symptomatic or asymptomatic patients having no signs of severe disease (NEWS score â?¤6) and no comorbidity at screening <br/ >4.Subject willing to provide consent and follow up for study duration <br/ >